GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Guangzhou Wondfo Biotech Co Ltd (SZSE:300482) » Definitions » Total Stockholders Equity

Guangzhou Wondfo Biotech Co (SZSE:300482) Total Stockholders Equity : ¥5,424 Mil (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Guangzhou Wondfo Biotech Co Total Stockholders Equity?

Guangzhou Wondfo Biotech Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥5,424 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Guangzhou Wondfo Biotech Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥11.49. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Guangzhou Wondfo Biotech Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.11.


Guangzhou Wondfo Biotech Co Total Stockholders Equity Historical Data

The historical data trend for Guangzhou Wondfo Biotech Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangzhou Wondfo Biotech Co Total Stockholders Equity Chart

Guangzhou Wondfo Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,223.33 2,842.30 3,353.10 4,343.93 4,515.97

Guangzhou Wondfo Biotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,554.12 4,498.12 4,533.65 4,515.97 5,423.71

Guangzhou Wondfo Biotech Co  (SZSE:300482) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Guangzhou Wondfo Biotech Co's Book Value per Share for the quarter that ended in Mar. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Guangzhou Wondfo Biotech Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guangzhou Wondfo Biotech Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Guangzhou Wondfo Biotech Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangzhou Wondfo Biotech Co (SZSE:300482) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Lizhishan Road, Science City, Luogang District, Guangdong, Guangzhou, CHN, 510641
Guangzhou Wondfo Biotech Co Ltd manufactures medical diagnostic tests. Its products include immunodiagnostic rapid test kits, including fertility, which include pregnancy HCG, ovulation LH, and others. The company's products are used in a clinical test, field test, and personal health management, among others.
Executives
He Xiao Wei Director
Kang Ke Ren Executives
Yu Fang Xia Executives
Li Wen Mei Directors, executives
Wang Ji Hua Director
Peng Zhong Xiong Executives
Zhao Ya Ping Executives
Luo Hong Supervisors
Zhou Yong Supervisors

Guangzhou Wondfo Biotech Co (SZSE:300482) Headlines

No Headlines